Track topics on Twitter Track topics that are important to you
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund I (£21m) and Avlar Fund II (£43m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought by public companies, two have been sold for cash and one is listed on the public markets. Prior to the formation of Avlar Messrs Roach and Goodman co-founded or seed financed nine life science companies. Seven of these were listed on recognized Stock Exchanges producing highly profitable realizations. These included Acambis, Chiroscience, Core, Salix and Oxford Biomedica.
Highfield CourtChurch Lane
Phone: 44 (0) 1954 211 515
Fax: 44 (0) 1954 211 516
At the annual Health 2.0 conference in Silicon Valley, a panel of venture capitalists describe areas of health tech that do not appeal to them.
A look at today's forthcoming news stories: GSK has stepped up its drive into emerging markets; an over the counter genetic testing kit is launched in the US, and the head of BioVentures for Global He...
NeuroVia Inc. (small-molecule therapeutics for rare CNS diseases) closed a $14mm Series A round co-led by Novartis Venture Fund and Sanofi-Genzyme BioVentures, which both added members to the company ...
In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Don Joseph, CEO of BioVentures for Global Health about the role of BVGH and their new ...
AnchorDx Corp of Guangzhou raised $28 million in a Series B round to develop precision oncology products using next-generation sequencing technology. The company's major focus applies NGS to methylate...
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund I (£21m) and Avlar Fund II (£43m). Avlar has invested in eighteen companies across a range of sub-sectors of the bio...
The commercial focus of De Novo is the exploitation of human genomics in drug discovery through in silico drug design. The company attracted £2 million financing in a first VC-backed investment roun...
Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...
BioVentures, Inc. is committed to the highest levels of scholarship through the submission of original research to peer reviewed publications and presentation of our data at scientific conferences. In...
Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing sc...
We have published hundreds of Avlar BioVentures Ltd news stories on BioPortfolio along with dozens of Avlar BioVentures Ltd Clinical Trials and PubMed Articles about Avlar BioVentures Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avlar BioVentures Ltd Companies in our database. You can also find out about relevant Avlar BioVentures Ltd Drugs and Medications on this site too.
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...